John Milad

John E Milad joined Downing as a Partner in January 2023 and is Co-Head of Healthcare Ventures.
John has 25 years’ experience as a start-up executive, board member, venture capital investor and investment banker specialising in the life sciences sector across the UK, Europe and the USA. ? John helped create Quanta Dialysis Technologies as an industrial spin-out from IMI plc in 2009 as an investor and founding board member.
From 2014, he served as Quanta’s CEO for eight years, where he transformed the company from an early-stage UK R&D team to an emerging global leader with transatlantic operations, a world-class team and an award-winning, portable haemodialysis system poised for market disruption.
During his tenure, Quanta commercially launched its offering in the UK and US markets, while raising nearly $400 million in funding and securing the prestigious MacRobert Award for engineering